Furosemide drug determination in pharmaceutical and biological urine samples using a novel continuous flow-injection analysis technique that is simple, rapid, sensitive and economical. The complex formed by the reaction of furosemide and O-phenylenediamine with oxidative agent K3[Fe(CN)6] to produce an orange-yellow colored product at 460 nm was the basis for the proposed method. The proposed method’s linearity ranges (3-100) μg.mL-1and (1-50) μg.mL-1 for CFIA/merging zone methods and batch .The detection limit and Limit of quantification values were 2.7502 μg.mL-1 and 9.1697 μg.mL-1 the relative standard deviation was 0.7143 %, and the average recovery is 98.80% with a verified sample throughput of 73 h-1 . The new approach was effectively employed to determination of furosemide the presence of in the pure, biological, and pharmaceutical samples.
